ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0944

Obstructive Sleep Apnea in Fibromyalgia Patients: A Meta-analysis

Nouran Eshak1, Wasawat Vutthikraivit1, Asmaa Beltagy2 and John Pixley3, 1Texas Tech Health Science Center, Lubbock, TX, 2Faculty of Medicine, Alexandria University, alexandria, egypt, Egypt, 3Texas Tech University HSC, Lubbock, TX

Meeting: ACR Convergence 2020

Keywords: fibromyalgia, pain, sleep

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 7, 2020

Title: Fibromyalgia & Other Clinical Pain Syndromes (0940–0944)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Fibromyalgia is a chronic pain disorder prevalent in about 3% of the population, mostly in females. A common complaint is non-restorative sleep.  Obstructive sleep apnea (OSA), the most common sleep related breathing disorder, has an estimated prevalence of 10-15% in females. It is characterized by upper airway collapse during sleep leading to apnea and hypopnea with poor fragmented sleep. Several studies have reported a positive correlation between chronic pain syndromes and sleep disorders. The link between OSA and pain syndromes is still unknown. It has been hypothesized that hyperalgesia occurs because of fragmented sleep and hypoxemia that enhance sensitivity to pain, promote inflammation, and increase spontaneous pain. Our study aimed to determine the incidence and prevalence of OSA in FM patients. 

Methods: We comprehensively searched the databases of MEDLINE, EMBASE, and Cochrane from inception to May 2020. Included studies were published observational studies (cohort or case-control) that investigated the incidence of OSA comparing patients with and without FM. We also included studies that reported the prevalence of OSA in FM. Data from each study were combined using the random-effects, generic inverse variance method of DerSimonian and Laird to calculate odd ratio and 95% confidence intervals.

Results: Fifteen studies from 1989 to 2020 were included in this meta-analysis involved ten studies reported prevalence and five case-control studies reported the incidence of OSA in FM patients. Pooled prevalence of OSA was 38.5 per 100 FM patients [95% confidence interval (CI): 24.4-52.6]. Incidence of OSA was significantly higher in patients with FM compared to without FM (pooled odd ratio = 3.51, 95% CI: 1.36-9.05, p = 0.008, I2=71.3%) (Figure1). There was no publication bias observed in Funnel plot as well as no small-study effect observed in Egger’s test (p-value = 0.921)

Conclusion: Our study demonstrated that there was a higher incidence and prevalence of OSA among FM patients. Polysomnography should be a standard diagnostic tool in the assessment of FM to unmask underlying treatable conditions that may contribute to the symptoms. As yet, there is no evidence that the treatment of OSA would lead to amelioration of chronic pain in FM. Further studies are needed to examine whether the treatment of the commonly detected OSA will have a beneficial effect on fibromyalgia symptoms.

Figure 1: Forest plot demonstrating the association between Fibromyalgia and the Incidence of Obstructive Sleep Apnea


Disclosure: N. Eshak, None; W. Vutthikraivit, None; A. Beltagy, None; J. Pixley, None.

To cite this abstract in AMA style:

Eshak N, Vutthikraivit W, Beltagy A, Pixley J. Obstructive Sleep Apnea in Fibromyalgia Patients: A Meta-analysis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/obstructive-sleep-apnea-in-fibromyalgia-patients-a-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/obstructive-sleep-apnea-in-fibromyalgia-patients-a-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology